1. Home
  2. MNKD vs STBA Comparison

MNKD vs STBA Comparison

Compare MNKD & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • STBA
  • Stock Information
  • Founded
  • MNKD 1991
  • STBA 1902
  • Country
  • MNKD United States
  • STBA United States
  • Employees
  • MNKD N/A
  • STBA N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • STBA Major Banks
  • Sector
  • MNKD Health Care
  • STBA Finance
  • Exchange
  • MNKD Nasdaq
  • STBA Nasdaq
  • Market Cap
  • MNKD 1.4B
  • STBA N/A
  • IPO Year
  • MNKD 2004
  • STBA N/A
  • Fundamental
  • Price
  • MNKD $4.56
  • STBA $37.60
  • Analyst Decision
  • MNKD Buy
  • STBA Hold
  • Analyst Count
  • MNKD 6
  • STBA 2
  • Target Price
  • MNKD $8.92
  • STBA $42.00
  • AVG Volume (30 Days)
  • MNKD 1.5M
  • STBA 150.9K
  • Earning Date
  • MNKD 05-08-2025
  • STBA 04-24-2025
  • Dividend Yield
  • MNKD N/A
  • STBA 3.61%
  • EPS Growth
  • MNKD 215.86
  • STBA N/A
  • EPS
  • MNKD 0.10
  • STBA 3.47
  • Revenue
  • MNKD $297,595,000.00
  • STBA $386,868,000.00
  • Revenue This Year
  • MNKD $14.23
  • STBA $5.52
  • Revenue Next Year
  • MNKD $14.56
  • STBA $5.37
  • P/E Ratio
  • MNKD $46.04
  • STBA $10.85
  • Revenue Growth
  • MNKD 32.50
  • STBA 0.79
  • 52 Week Low
  • MNKD $4.17
  • STBA $29.85
  • 52 Week High
  • MNKD $7.63
  • STBA $45.79
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 38.80
  • STBA 58.22
  • Support Level
  • MNKD $4.42
  • STBA $36.13
  • Resistance Level
  • MNKD $5.05
  • STBA $38.32
  • Average True Range (ATR)
  • MNKD 0.18
  • STBA 1.09
  • MACD
  • MNKD 0.00
  • STBA 0.27
  • Stochastic Oscillator
  • MNKD 20.59
  • STBA 81.73

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: